Search

everythinglearnresearchcommunity

for

Search:↓

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Cicatricial alopecia can progress to complete hair loss, making diagnosis and management difficult.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

The higher dose supplement was more effective in treating female hair loss.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

The treatment slightly increased hair growth and was safe for most women.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Certain gene variations may increase the risk and severity of alopecia areata.